Benzinga | Nov 30, 2021 04:06PM EST

Earnings Preview For Redhill Biopharma

Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Tuesday, 2021-11-30. Here's what investors need to know before the announcement.

Analysts estimate that Redhill Biopharma will likely report an Earnings Per Share (EPS) of $-0.21.

Redhill Biopharma bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.06, which was followed by a 6.45% increase in the share price the next day.

Here's a look at Redhill Biopharma's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020EPS Estimate -0.12 -0.34 -0.24 -0.16EPS Actual -0.06 -0.05 -0.07 -0.05Price Change % 6.45% 1.54% 1.21% 4.87%

Stock Performance

Shares of Redhill Biopharma were trading at $3 as of November 26. Over the last 52-week period, shares are down 66.12%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

If you want to track all upcoming earnings announcements, check out our Earnings Calendar here